Abstract
The role of chemotherapy and radiotherapy in adjuvant management of optimally debulked endometrial cancer with extrauterine involvement is evolving. Recent studies have suggested an expanded role for chemotherapy and questioned the benefit of radiation therapy. Ongoing and planned clinical trials should provide clarification.
| Original language | English |
|---|---|
| Pages (from-to) | 535-541 |
| Number of pages | 7 |
| Journal | JNCCN Journal of the National Comprehensive Cancer Network |
| Volume | 7 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2009 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adjuvant chemotherapy
- Adjuvant radiotherapy
- Chemoradiotherapy
- Endometrial cancer
- Surgery
- Surgical staging
ASJC Scopus subject areas
- Oncology
Fingerprint
Dive into the research topics of 'Chemo- and radiotherapy in adjuvant management of optimally debulked endometrial cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver